Navigation Links
Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients

Broadest, Most Comprehensive Survey Provides New Benchmark on MRSA in Healthcare Facilities

WASHINGTON, June 21, 2007 /PRNewswire-USNewswire/ -- The following was released today by APIC:


    -- First nationwide study of the prevalence of Methicillin-resistant

       Staphylococcus aureus (MRSA), a virulent multi-drug resistant organism,

       in U.S. healthcare facilities.

    -- MRSA prevalence study findings significantly exceed previous estimates

       and will for the first time provide a picture of the threat MRSA poses

       to patients in facilities caring for virtually every type of patient,

       including acute care, cancer, cardiac, pediatric, rehabilitation and

       long-term care.

    -- The study, funded by the Association for Professionals in Infection

       Control and Epidemiology (APIC), collected data from more than 1,200

       healthcare facilities in all 50 states to determine the current

       magnitude of MRSA.

    -- Results and implications from the study on MRSA will be discussed at

       APIC's 34th Annual Conference & International Meeting.


      12:00 p.m. Eastern, 9:00 a.m. Pacific, Tuesday, June 26, 2007

      San Jose, CA     Marriott, Guadalupe Room

      301 South Market Street (Directions,


      Media call-in connection: 800-308-9694, enter 400179

      For study results, please go to: (link

      will be live at 12:01 am, 6/25/07)


    -- In 1972, MRSA accounted for only two percent of all Staphylococcus

       aureus healthcare-associated infections (HAIs) reported to the Centers

       for Disease Control and Prevention (CDC). Today, MRSA accounts for more

   than 60 percent of Staphylococcus aureus infections.

    -- The MRSA death rate has been estimated to be more than 2.5 times higher

       than infections from Staphylococcus aureus that are susceptible to


    -- While there are a few national MRSA estimates, these are limited in

       scope and size, and therefore, the true magnitude of the total burden

       of MRSA in the U.S. healthcare population is unknown.


    -- Kathy Warye -- Chief Executive Officer, APIC

    -- Denise Murphy, RN, MPH, CIC -- 2007 APIC President

    -- William Jarvis, M.D. -- President, Jason and Jarvis Associates


    Journalists wishing to participate in the press briefing in person or via

    telephone and/or arrange interviews please call Jonathan Osmundsen at

    202-261-2869, email: .

CONTACT: Jonathan Osmundsen, +1-202-261-2869,, for APIC

Web site:

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


Related medicine technology :

1. Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting
2. First-of-its-Kind National Report Reveals Estimated High Prevalence and Heavy Cost of Type 2 Diabetes Complications in America
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
5. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
Post Your Comments:
(Date:12/1/2015)... 2015 Pharma Tech Outlook recently conducted a ... Data Management Solution Providers - 2015 .  After careful ... CEOs, CIOs, VCs, analysts, and the Pharma Tech Outlook ... top 10 clinical data management solution providers (check out ... and 36 respectively). --> ...
(Date:12/1/2015)... , 1 de diciembre de 2015 ... tecnología para cuchillas de precisión, develó hoy ... de identidad de marca. El nuevo logo ... diseño y la ingeniería de productos con ... diferencia". ...
(Date:12/1/2015)... -- Six months of adjunctive metformin therapy does not improve glycemic ... new research from T1D Exchange and funded by ... effect on measures of obesity, including weight and BMI. The ... of the American Medical Association , are from the largest ... overweight and obese adolescents with type 1 diabetes. ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates mobile ... wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they are ... of North America (RSNA) 2015 annual meeting through December 3 in Chicago, Illinois, ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... that it has been selected as a finalist in this year’s Fierce Innovation ... FierceMobileHealthcare. Next IT Healthcare was recognized as a finalist in the category of ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Lutronic, ... release of Clarity, the latest addition to the devices for sale in the United ... 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s latest ... Integration ,” addresses a main “pain point” for merging or aligning healthcare provider ... a deal is signed. This quick-read guidance suggests that failing to recognize ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , ... membership and leadership since 2008. Gary Bruce, President of PartnerTech North America, currently ... spent a significant amount of time in Sweden since joining PartnerTech based in ...
Breaking Medicine News(10 mins):